ALS & Motor Neuron Disease Supportive Care
ALS & Motor Neuron Disease Supportive Care framework focused on consistent execution, practical monitoring, and safer progression.
A neuroprotective peptide protocol for ALS and motor neuron disease, targeting mitochondrial function, neuroinflammation, and remaining motor neuron survival without interfering with standard-of-care riluzole therapy.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
ALS & Motor Neuron Disease Supportive Care Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing; reassess every 12 weeks with neurologist
Target Audience
ALS patients on standard of care, under neurologist supervision
| Compound | Dose | Frequency |
|---|---|---|
| Cerebrolysin Neurotrophic peptide complex for motor neuron support. | 5 mL (215 mg) | Once daily |
| Humanin STAT3 activation, motor neuron apoptosis reduction. | 0.5 mg | 3x/week |
| Semax BDNF/NGF upregulation, spinal cord anti-inflammatory. | 200 mcg | Once daily |
| MOTS-c Mitochondrial biogenesis, AMPK activation. | 5 mg | 3x/week |
| NAD+ NAD+ replenishment for mitochondrial function and sirtuin activation. | 500 mg | Once daily |
Free Peptide Guide
ALS & Motor Neuron Disease Supportive Care Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Cerebrolysin timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should ALS & Motor Neuron Disease Supportive Care run before reassessment?
A common window is Ongoing; reassess every 12 weeks with neurologist, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Cerebrolysin + Humanin execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Cerebrolysin delivers a complex of neurotrophic peptides (BDNF-like, CNTF-like fractions) that support surviving motor neurons and slow axonal degeneration. Humanin activates ALS-relevant neuroprotective pathways including STAT3/JAK, reducing apoptosis in stressed motor neurons. Semax upregulates BDNF and NGF while reducing spinal cord neuroinflammation. MOTS-c and NAD+ address the profound mitochondrial dysfunction that accelerates ALS progression, improving cellular energy economy in surviving neurons.
Clinical Research
No clinical references were provided for this stack yet.
More Recovery & Repair Stacks
Acute Injury & Emergency Recovery Protocol
Rapid-response peptide protocol for acute injuries, post-surgical recovery, or critical illness support. Designed to initiate within 24–48 hours of injury or procedure.
Advanced Gut Restoration Protocol
The most comprehensive gut healing protocol, targeting intestinal permeability, mucosal growth, epithelial repair, and microbiome defense simultaneously. Suitable for celiac disease, post-antibiotic dysbiosis, IBD, short bowel syndrome, and chronic leaky gut.
Alcohol Use Disorder Recovery & Liver Restoration Protocol
Comprehensive recovery protocol for alcohol use disorder targeting hepatic repair, neurochemical rebalancing, dopamine system restoration, gut microbiome repair, and craving reduction.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
ALS & Motor Neuron Disease Supportive Care Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.